BeStock  
Stocks › Biotechnology › NTLA

Intellia Therapeutics NTLA

US equityMarket cap rank #2922BiotechnologyGene Editing
$10.00 +$0.48 (+5.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.00 +0.01%
Open$9.34
Prev close$9.52
Day range$9.30 – $10.40
Volume15.19M
Market cap$1.40B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

NTLA at a glance

Intellia Therapeutics stock (NTLA) sits at $10.00, up 5.04% today. The business is worth $1.40B in the market, good for #2922 of 3753 on our coverage list.

The 52-week range is $8.09 to $18.48. Today's price is about 18% of the way from the low to the high. Holders are ahead 21.8% over twelve months, but down 20.4% across the last three months.

On the chart it has slipped under both the 50-day ($11.67) and 200-day ($12.89) moving averages; RSI is 41, and the last 30 sessions moved at roughly 78% annualized volatility.

Revenue for the quarter ended Sep 2026 was $7.16M, down 48.0% from a year earlier, and a net loss of $127.49M.

11 analysts follow the stock and the average call is "hold". The mean target, $19.20, sits 92.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$10.00 / $10.30
Average price today$10.05
Volume15.19MAvg (90d) 4.60M
Turnover$152.73M
Turnover rate11.30%of shares outstanding
Volume ratio1.77vs. recent average pace
Day amplitude11.50%
Market cap$1.40B
Float market cap$1.34B
Shares outstanding134.45M
EPS (TTM)-$3.81
P/B2.29
Book value / share$4.37
Net profit (TTM)-$534.77M
Net assets$613.09M
30-day volatility77.8%annualized
Avg daily range (ATR)8.52%of price, 14 days
Max drawdown (1y)-46.6%-43.9% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

C
Wall Street

11 analysts, consensus Hold.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 18.1 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability2.8
Momentum32.8
Financial health92.8
Analyst view52.1

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$19.20+92.0% vs. current price
Consensus ratingHold11 analysts covering
Morningstar fair value$27.00Price is below fair value

Wall Street’s average 12-month target is $19.20, 92.0% above today’s price, with a consensus rating of Hold. Morningstar’s fair value model puts the stock at $27.00, so shares trade 63.0% below that estimate. On earnings multiple, it sits in the 78th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+5.0%
1 week
+3.1%
1 month
-10.4%
3 months
-20.4%
6 months
-20.6%
Year to date
+11.2%
1 year
+21.8%
Day range
$9.30$10.40
52-week range
$8.09$18.48

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-11.0%Bearish
Price vs 50-day average-14.3%Bearish
Price vs 200-day average-22.4%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)40.7Bearish
MACD (12,26,9)-0.60Bearish
Bollinger band position24%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How NTLA ranks on BeStock

Market value#2910 of 3734
Closeness to 52-week high#2884 of 3724
Dollar volume today#766 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

NTLA is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on NTLA.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on NTLA

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

NTLA stock: common questions

Where is NTLA trading right now?

$10.00 is the latest print for NTLA, a move of +5.04% against yesterday's close of $9.52. Today's low and high so far: $9.30 and $10.40.

How big is Intellia Therapeutics?

Equity value comes to $1.40B at the current price. By that measure it is number 2922 of the 3753 names in our coverage.

Is NTLA near its 52-week high or low?

The year's floor is $8.09 and the ceiling $18.48. Shares are 45.9% away from that ceiling.

Does Intellia Therapeutics pay a dividend?

Our data shows no dividend paid by Intellia Therapeutics over the trailing twelve months.

Is NTLA rated a buy by Wall Street?

Of 11 analysts, 36% say buy, 45% hold and 18% sell. Price targets average $19.20, with the most cautious at $8.00 and the most optimistic at $49.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on NTLA.

Sign in to join the discussion.

Scroll to Top